Published in

Springer, Metabolomics, 3(9), p. 740-751, 2012

DOI: 10.1007/s11306-012-0489-2

Links

Tools

Export citation

Search in Google Scholar

A proton nuclear magnetic resonance-based metabolomic approach in IgA nephropathy urinary profiles

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Immunoglobulin A nephropathy (IgAN) is the most common form of primary glomerulonephritis world-wide. Both one-dimensional NOESY and transverse-relax-ation filter CPMG NMR spectra were recorded to investigate the urine metabolome of 24 IgAN patients and to detect altered metabolic profiles in comparison with 68 healthy matched controls. The spectral data were analyzed using multivariate statistical techniques. The analysis revealed that the NMR spectra of IgAN patients were statistically differ-ent from those of the controls (P = 4 9 10 -7 for 1D-NO-ESY and P = 2 9 10 -7 for CPMG). The robustness of the determined statistical model was confirmed by its predictive performance (for the 1D-NOESY dataset: sensitiv-ity = 67 %, specificity = 95 %; for the CPMG dataset sensitivity = 60 %, specificity = 94 %). For the first time we found metabolites, including betaine and citrate, that are differentially modulated in IgAN patients compared to controls and that may be directly involved in the patho-genesis of IgAN. These metabolites may influence, directly or indirectly, the TNF-a, a regulating factor of the Th1/Th2 cell balance that is relevant in the pathology. The involve-ment of metabolites such as betaine and citrate in TNF-a regulation supports the power of the identified metabolic profiles to discern IgAN from controls.